Phosphoglucomutase 3

Clinical significance

Mutations in PGM3 are associated to congenital disorder of glycosylation.[7]

References

  1. GRCh38: Ensembl release 89: ENSG00000013375 - Ensembl, May 2017
  2. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  3. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. Pang H, Koda Y, Soejima M, Kimura H (Aug 2002). "Identification of human phosphoglucomutase 3 (PGM3) as N-acetylglucosamine-phosphate mutase (AGM1)". Ann Hum Genet. 66 (Pt 2): 139–44. doi:10.1046/j.1469-1809.2002.00103.x. PMID 12174217.
  5. Li C, Rodriguez M, Banerjee D (Apr 2000). "Cloning and characterization of complementary DNA encoding human N-acetylglucosamine-phosphate mutase protein". Gene. 242 (1–2): 97–103. doi:10.1016/S0378-1119(99)00543-0. PMID 10721701.
  6. "Entrez Gene: PGM3 phosphoglucomutase 3".
  7. Stray-Pedersen, A; Backe, P. H.; Sorte, H. S.; Mørkrid, L; Chokshi, N. Y.; Erichsen, H. C.; Gambin, T; Elgstøen, K. B.; Bjørås, M; Wlodarski, M. W.; Krüger, M; Jhangiani, S. N.; Muzny, D. M.; Patel, A; Raymond, K. M.; Sasa, G. S.; Krance, R. A.; Martinez, C. A.; Abraham, S. M.; Speckmann, C; Ehl, S; Hall, P; Forbes, L. R.; Merckoll, E; Westvik, J; Nishimura, G; Rustad, C. F.; Abrahamsen, T. G.; Rønnestad, A; et al. (2014). "PGM3 Mutations Cause a Congenital Disorder of Glycosylation with Severe Immunodeficiency and Skeletal Dysplasia". The American Journal of Human Genetics. 95 (1): 96–107. doi:10.1016/j.ajhg.2014.05.007. PMC 4085583. PMID 24931394.

Further reading

  • Overview of all the structural information available in the PDB for UniProt: Q9CYR6 (Mouse Phosphoacetylglucosamine mutase) at the PDBe-KB.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.